Banard Charlene A. has filed 3 insider transactions across 1 company since March 2023.
Most recent transaction: a sale of 19040 shares of Atara Biotherapeutics, Inc. ($ATRA) on May 16, 2023.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Banard Charlene A. | EVP, Chief Technical Officer | S | Common Stock | 19040 | $2.04 | 276,010.0000 | 0 | 6.45% | 0.00% |
| March 1, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Banard Charlene A. | EVP, Chief Technical Officer | A | Common Stock | 139700 | $0.00 | 295,050.0000 | 0 | 89.93% | 0.00% |
| March 1, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Banard Charlene A. | EVP, Chief Technical Officer | A | Employee Stock Option (Right to Buy) | 314325 | $0.00 | 314,325.0000 | 0 | 9999.99% | 0.00% |